Nkarta Statistics

NASDAQ: NKTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.22-0.05 (-2.20%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Nkarta by the numbers

Nkarta has a market capitalization of $159.0 million based on 71.62M shares outstanding. With trailing EPS of $-1.58, Nkarta is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.6% below its 50-day average and 12.7% below its 200-day average.

Average daily trading volume is 613.16K shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NKTX valuation vs. peer median

NKTX compared with the median of 8 peer companies
Metric	NKTX	Peer median	Difference
Market cap	$159.01M	$159.29M	-0%
Avg. volume	613.16K	225.39K	+172%

Peer median across 8 companies: NBP, MENS, EMIS, CUE, KRRO, ALXO, VRXA, NERV.

Valuation

Market cap: $159.01M
P/E (TTM): —
Forward P/E: —
EPS (TTM): $-1.58
Shares outstanding: 71.62M

Price and trading

Previous close: 2.27
Open: 2.23
Day range: 2.16 – 2.26
52-week range: 1.70 – 3.72
52-week change: +6.22%
50-day moving average: 2.60
200-day moving average: 2.54
Beta: —
Volume: 720.14K
Average volume: 613.16K

Dividends and events

Annual dividend: None
Dividend yield: —
Ex-dividend date: —
Next earnings date: Nov 10, 2026

Additional statistics

Market Cap: 159.01M
Forward Pe: -1.27
Eps: -1.58
Dividend Yield: 0.00%
Dividend Rate: 0.00
Week52 High: 3.72
Week52 Low: 1.70
Avg Volume: 613.16K
Shares Outstanding: 71.62M
Ma50: 2.60
Ma200: 2.54
Earnings Date: Nov 10, 2026
Pct From52w High: -40.32%
Pct From52w Low: 30.59%